Aleafia Health Inc., together with its subsidiaries, operates as cannabis health and wellness company in Canada, Europe, and Australia. The company owns and operates a virtual network of medical cannabis clinics staffed through physicians and nurse practitioners. Its product portfolio includes cannabis oils, capsules, edibles, cannabis-infused sublingual strips, pre-roll, milled, and vape cartridges; bath bombs and soft gels; hang dried, hand trimmed, long cured, and small batch dried flower; and concentrates. It offers its products under the Divvy, Sunday Market, Bogart's Kitchen, Noon & Night, Nith & Grand, Kin Slips, and Emblem brands. Aleafia Health Inc. is headquartered in Concord, Canada.
Research context
Aleafia Health Inc appears in PyInvesting’s Toronto Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CAD
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Apr 1, 2021
Aleafia Health Inc is currently in a long term downtrend where the price is trading 29.7% below its 200 day moving average.
From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.1.
Aleafia Health Inc's total revenue rose by 152.2% to $15M since the same quarter in the previous year.
Its net income has dropped by 2126.7% to $-217M since the same quarter in the previous year.
Finally, its free cash flow fell by 57.0% to $-7M since the same quarter in the previous year.
Based on the above factors, Aleafia Health Inc gets an overall score of 2/5.